(UroToday.com) Investigators from Erasmus University Medical Center, The Netherlands, presented their analysis of high-throughput genomic profiling of biopsies from patients with metastatic urothelial carcinoma. Using whole-genome DNA sequencing and RNAseq analyses, they provided a comprehensive overview of alterations in metastatic bladder cancer.